LXH-2301
N/A
Report date: 2025/10/24 16:19:09
Base Information
Drug NameLXH-2301
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Nuo BHP New Drug Research and Development Co LtdShandong Xinhua Pharmaceutical Company Ltd
China Registration ClassN/A
Develop Information
Active CompaniesJiangsu Nuo BHP New Drug Research and Development Co LtdShandong Xinhua Pharmaceutical Company Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A